Home > LACID: Laboratory of Cooperative Activity in R+D+I

LACID: Laboratory of Cooperative Activity in R+D+I

The Cooperative R+D+I Activity Laboratory (LACID, according to its Spanish initials) provides a framework for cooperation between the IMDEA Food Institute and the I+D departments of private companies and public research institutes (Spanish and foreign), in which funding, human resources, spaces and infrastructures can be shared for joint R+D+I projects in nutrition and health.

LACID has the objective of bringing together science and the agrifood industry in order to provide better opportunities for improving competitiveness and social wellbeing for the Region of Madrid and indeed the whole of Spain.

For the last 30 years, the international scientific community has known that the mechanisms causing a range of chronic diseases can be influenced by diet.  Disease can be delayed, and in many cases general health can be improved. However, there has been only limited success in translating this into food products and nutritional strategies capable of bringing this about and this is the reason because stakeholders in the field need to work more closely together if society is to gain from the scientific knowledge available. 

In addition to the priority goal of improving health and wellbeing, the new context of research into nutrition, offers opportunities for improving competitiveness in the food industry and the generation of wealth, contributing towards an economic model based on science, technology and innovation. 

LACID TEAM

General Director:​                        Scientific Directors:                       Administrative Director:
 
Prof. Guillermo Reglero             Prof. Guillermo Reglero                  Inmaculada Galindo
                                                    Dr. Ana Ramírez de Molina  

Associate Researchers:

Dr. Manuel Serrano Marugán
Head of the Tumour Suppression Group and Director of the Molecular Oncology Program, Spanish National Cancer Research Center

Manuel Serrano is a researcher at the Spanish National Cancer Research Centre (CNIO), in Madrid, and Director of the Molecular Oncology Program of the CNIO. After completing his studies and PhD in Madrid, M.S. joined the laboratory of David Beach, at Cold Spring Harbor Laboratory, NY, USA, as postdoctoral fellow from 1992 to 1996.  During this time, Manuel Serrano made one of his most important contributions with the discovery of the tu-mor suppressor p16. Manuel Serrano established his research group, first at the National Center of Biotechnology, Madrid, and since 2003 at the CNIO. The main contributions of the Serrano´s laboratory during these years are related to the concept of oncogene-induced senescence and the anti-aging activity of tumor suppressors. More recently, Serrano´s group has reported on the relevance of tumor suppressors in metabolic Syndrome, the existence of senescence during embryonic development, and the feasibility of embryonic reprogramming within alive adult organisms (the latter was considered “Achievement of the Year 2013” in the stem cells field by Nature Medici-ne). The unifying theme of Manuel Serrano´s research is to understand and manipulate cellular stress responses in relation to cancer and regeneration.

Dr. Enrique Casado Sáenz
Head of the Medical Oncology Department, Infanta Sofía University Hospital and Oncology Coordinating Professor of Oncology, European University of Madrid

Enrique Casado finished his undergraduate studies in Medicine and Surgery (1992) and Biohealth Sciences (1993) in Complutense University of Madrid (Universidad Complutense de Madrid) (UCM). He obtained the Degree of Doc-tor of Medicine (1994) with Extraordinary Prize granted by UCM. He did his medical residency in La Paz University Hospital (Hospital Universitario de la Paz) (1993-97) and Master’s Degree in Palliative Care (1997) in Universidad Autónoma de Madrid (UAM), in combination with extended postdoctoral internships in University of Alabama (Birmingham) and University of Ca-lifornia (San Francisco). He was the attending physician of Medical Oncology in gastrointestinal and thoracic cancer and laboratory coordinator for the Translational Oncology Unit of Hospital Universitario de la Paz (Madrid). He is an associate professor of UAM and visiting professor of UCM. He is currently the Head of Medical Oncology Department at the Hospital Universitario Infanta Sofía de Madrid and a Coordinating Professor of Oncology in the Universidad Europea de Madrid. He has received 7 awards in recognition of his research work from institutions as prestigious as the American Society of Clinical Oncology.

Dr. Jaime Feliú Batlle
Head of the Medical Oncology Department, La Paz University Hospital

Dr. Jaime Feliú Batlle holds a Degree in Medicine and Surgery from Universidad Complutense de Madrid issued in 1982. He specialized in Medical Oncology in Hospital Universitario de la Paz, where he is currently the Head of Medical Oncology Department. He is a professor of oncology in the Medicine Area of Universidad Autónoma de Madrid (UAM) and Director of Master´s Degree in Palliative Care and Treatments for Cancer Patient Support of UAM. Furthermore, he is the current president of the Multidisciplinary Spanish Group of Digestive Cancer (GEMCAD).He has participated as a principal investigator or co-investigator in more than 70 phase I, II and III trials. He has written or co-written more than 200 articles for national and international journals, more than 60 book chapters and has presented a large number of communications in national and international congresses.